BELLUS Health Quote Page (BLUS.PK)

DJIA	12,454.83	-74.92	-0.60%
NASDAQ	2,837.53	-1.85	-0.07%
S&P 500	1,317.82	-2.86	-0.22%

Victoria Square Ventures Inc. holdings of BELLUS Health Inc. securities reorganized by arrangement

5/25/2012 by PR Newswire

Bellus Health to Present at BioFinance 2012

5/25/2012 by StockWatch

Bellus Health loses $3.19-million in Q1 2011

5/15/2012 by StockWatch

Bellus Health to sell 10.4% of itself to Pharmascience

4/5/2012 by StockWatch

Bellus Health earns $3.42-million in 2011

2/22/2012 by StockWatch

Bellus Health starts selling Vivimind in Canada

11/28/2011 by StockWatch

Bellus Health earns $245,000 in Q3 2011

11/9/2011 by StockWatch

BELLUS Health reports results for third quarter ended September 30, 2011, and provides update on VIVIMIND™ partnerships

11/9/2011 by StockWatch

BELLUS Health reports results for second quarter ended June 30, 2011

8/10/2011 by PR Newswire

Crystal Research Associates Issues Research Report on BELLUS Health Inc. (TOR:BLU)

7/14/2011 by AccessWire

Quebec No. 2 Holdings, LLC: Acquisition of Shares of BELLUS Health Inc.

4/8/2011 by Product Design and Development

Quebec No. 2 Holdings, LLC: Acquisition of Shares of BELLUS Health Inc.

4/8/2011 by StockHouse

Quebec No. 2 Holdings, LLC: Acquisition of Shares of BELLUS Health Inc.

4/8/2011 by Marketwire

BELLUS HEALTH ISSUES SHARES IN FINAL PAYMENT FOR THE EXERCISE OF ITS LEASE TERMINATION OPTION

4/7/2011 by StockWatch

Bellus Health Completes Restructuring Initiatives With Repatriation of Intellectual Property to Canada

4/5/2011 by PharmaLive

Bellus Health signs licence agreement for Viviminda

4/4/2011 by StockWatch

Bellus Health cuts annual burn rate by $1.4-million

3/31/2011 by StockWatch

Bellus Health loses $20.11-million in 2010

2/23/2011 by StockWatch

Bellus Health 'pleased' with phase 1 trial of its Alzheimer's drug; stock soars

1/31/2011 by Canadian Business - Canada

Bellus Health investor Quebec No. 2 Holdings owns 13%

1/20/2011 by StockWatch

Bellus Health Exercises Option to Terminate Lease

1/14/2011 by PharmaLive

BELLUS HEALTH EXERCISES OPTION TO TERMINATE LEASE

1/14/2011 by StockHouse

Bellus Health to sell Cdn subsidiary for $1-million

1/4/2011 by StockWatch

CELTIC THERAPEUTICS AND BELLUS HEALTH INITIATE CONFIRMATORY PHASE III CLINICAL STUDY FOR KIACTA?, A DRUG CANDIDATE FOR THE TREATMENT OF AA AMYLOIDOSIS

12/16/2010 by Biocompare

Crystal Research Associates Issues Updated Report on BELLUS Health Inc.

12/16/2010 by StockHouse

Crystal Research Associates Issues Updated Report on BELLUS Health Inc. (TOR:BLU)

12/16/2010 by AccessWire

Celtic Therapeutics and Bellus Health Initiate Confirmatory Phase III clinical Study for Kiacta, a Drug Candidate for the Treatment of AA Amyloidosis

12/15/2010 by PharmaLive

Market Report, "BELLUS Health Inc - Product Pipeline Review - Q4 2010", published

11/19/2010 by PR-inside - Austria

Bellus Health to cut two-thirds of its employees over the next year

8/9/2010 by Product Design and Development

Bellus Health reports results for second quarter ended June 30, 2010

8/9/2010 by StockHouse

Bellus Health loses $5.81-million in Q2 2010

8/9/2010 by StockWatch

BELLUS Health Inc (BLU) - Financial and Strategic Analysis Review - new company profile and analysis released

7/23/2010 by PR-inside - Austria

Geller Biopharm Successfully Advises BELLUS Health in Its KIACTA(TM) Transaction With Celtic Therapeutics

4/30/2010 by GlobeNewswire

MDVN Falls on Alzheimer's Data - Analyst Blog

3/4/2010 by Zacks Investment Research

Ticker

BELLUS Health